[B01AD01, streptokinase, The risk or severity of adverse effects can be increased when Streptokinase is combined with Collagenase clostridium histolyticum.]
[B01AE07, dabigatran etexilate, The risk or severity of adverse effects can be increased when Dabigatran etexilate is combined with Collagenase clostridium histolyticum.]
[S03AA02, tetracycline, The therapeutic efficacy of Collagenase clostridium histolyticum can be decreased when used in combination with Tetracycline.]
[B01AD04, urokinase, The risk or severity of adverse effects can be increased when Urokinase is combined with Collagenase clostridium histolyticum.]
[B01AF01, rivaroxaban, The risk or severity of adverse effects can be increased when Rivaroxaban is combined with Collagenase clostridium histolyticum.]
[B01AC24, ticagrelor, The risk or severity of adverse effects can be increased when Ticagrelor is combined with Collagenase clostridium histolyticum.]
[B01AA03, warfarin, The risk or severity of adverse effects can be increased when Warfarin is combined with Collagenase clostridium histolyticum.]
[B01AE01, desirudin, The risk or severity of adverse effects can be increased when Lepirudin is combined with Collagenase clostridium histolyticum.]
[B01AX01, defibrotide, The risk or severity of adverse effects can be increased when Defibrotide is combined with Collagenase clostridium histolyticum.]
[B01AF02, apixaban, The risk or severity of adverse effects can be increased when Apixaban is combined with Collagenase clostridium histolyticum.]
[B01AE03, argatroban, The risk or severity of adverse effects can be increased when Argatroban is combined with Collagenase clostridium histolyticum.]
[B01AC26, vorapaxar, The risk or severity of adverse effects can be increased when Vorapaxar is combined with Collagenase clostridium histolyticum.]
[B01AA07, acenocoumarol, The risk or severity of adverse effects can be increased when Acenocoumarol is combined with Collagenase clostridium histolyticum.]
[B01AA01, dicumarol, The risk or severity of adverse effects can be increased when Dicoumarol is combined with Collagenase clostridium histolyticum.]
[B01AF03, edoxaban, The risk or severity of adverse effects can be increased when Edoxaban is combined with Collagenase clostridium histolyticum.]
[B01AA11, tioclomarol, The risk or severity of adverse effects can be increased when Tioclomarol is combined with Collagenase clostridium histolyticum.]
[B01AC25, cangrelor, The risk or severity of adverse effects can be increased when Cangrelor is combined with Collagenase clostridium histolyticum.]
[B01AF04, betrixaban, The risk or severity of adverse effects can be increased when Betrixaban is combined with Collagenase clostridium histolyticum.]
[J01AA13, eravacycline, The therapeutic efficacy of Collagenase clostridium histolyticum can be decreased when used in combination with Eravacycline.]
[J01AA14, sarecycline, The therapeutic efficacy of Collagenase clostridium histolyticum can be decreased when used in combination with Sarecycline.]
[J01AA15, omadacycline, The therapeutic efficacy of Collagenase clostridium histolyticum can be decreased when used in combination with Omadacycline.]
[J01AA11, clomocycline, The therapeutic efficacy of Collagenase clostridium histolyticum can be decreased when used in combination with Clomocycline.]
[B01AE02, lepirudin, The risk or severity of adverse effects can be increased when Lepirudin is combined with Collagenase clostridium histolyticum.]
[S01AA02, chlortetracycline, The therapeutic efficacy of Collagenase clostridium histolyticum can be decreased when used in combination with Chlortetracycline.]
[B01AD11, tenecteplase, The risk or severity of adverse effects can be increased when Tenecteplase is combined with Collagenase clostridium histolyticum.]
[B01AB12, bemiparin, The risk or severity of adverse effects can be increased when Bemiparin is combined with Collagenase clostridium histolyticum.]
[D10AF04, meclocycline, The therapeutic efficacy of Collagenase clostridium histolyticum can be decreased when used in combination with Meclocycline.]
[J01AA01, demeclocycline, The therapeutic efficacy of Collagenase clostridium histolyticum can be decreased when used in combination with Demeclocycline.]
[B01AX05, fondaparinux, The risk or severity of adverse effects can be increased when Fondaparinux is combined with Collagenase clostridium histolyticum.]
[B01AC07, dipyridamole, The risk or severity of adverse effects can be increased when Dipyridamole is combined with Collagenase clostridium histolyticum.]
[B01AD10, drotrecogin alfa, The risk or severity of adverse effects can be increased when Drotrecogin alfa is combined with Collagenase clostridium histolyticum.]
[J01AA02, doxycycline, The therapeutic efficacy of Collagenase clostridium histolyticum can be decreased when used in combination with Doxycycline.]
[J01AA12, tigecycline, The therapeutic efficacy of Collagenase clostridium histolyticum can be decreased when used in combination with Tigecycline.]
[B01AC18, triflusal, The risk or severity of adverse effects can be increased when Triflusal is combined with Collagenase clostridium histolyticum.]
[C05CA04, troxerutin, The risk or severity of adverse effects can be increased when Troxerutin is combined with Collagenase clostridium histolyticum.]
[B01AD03, anistreplase, The risk or severity of adverse effects can be increased when Anistreplase is combined with Collagenase clostridium histolyticum.]
[B05AA05, dextran, The risk or severity of adverse effects can be increased when Dextran is combined with Collagenase clostridium histolyticum.]
[B01AD05, plasmin, The risk or severity of adverse effects can be increased when Fibrinolysin is combined with Collagenase clostridium histolyticum.]
[B01AA12, fluindione, The risk or severity of adverse effects can be increased when Fluindione is combined with Collagenase clostridium histolyticum.]
[S01XA14, heparin, The risk or severity of adverse effects can be increased when Heparin is combined with Collagenase clostridium histolyticum.]
[B05CB02, sodium citrate, The risk or severity of adverse effects can be increased when Sodium citrate is combined with Collagenase clostridium histolyticum.]
[B01AE06, bivalirudin, The risk or severity of adverse effects can be increased when Bivalirudin is combined with Collagenase clostridium histolyticum.]
[B01AC22, prasugrel, The risk or severity of adverse effects can be increased when Prasugrel is combined with Collagenase clostridium histolyticum.]
[J01AA04, lymecycline, The therapeutic efficacy of Collagenase clostridium histolyticum can be decreased when used in combination with Lymecycline.]
[B01AB06, nadroparin, The risk or severity of adverse effects can be increased when Nadroparin is combined with Collagenase clostridium histolyticum.]
[B01AB05, enoxaparin, The risk or severity of adverse effects can be increased when Enoxaparin is combined with Collagenase clostridium histolyticum.]
[B01AB04, dalteparin, The risk or severity of adverse effects can be increased when Dalteparin is combined with Collagenase clostridium histolyticum.]
[J01AA05, methacycline, The therapeutic efficacy of Collagenase clostridium histolyticum can be decreased when used in combination with Metacycline.]
[B01AB07, parnaparin, The risk or severity of adverse effects can be increased when Parnaparin is combined with Collagenase clostridium histolyticum.]
[B01AB10, tinzaparin, The risk or severity of adverse effects can be increased when Tinzaparin is combined with Collagenase clostridium histolyticum.]
[J01AA08, minocycline, The therapeutic efficacy of Collagenase clostridium histolyticum can be decreased when used in combination with Minocycline.]
[B01AB08, reviparin, The risk or severity of adverse effects can be increased when Reviparin is combined with Collagenase clostridium histolyticum.]
[B01AD07, reteplase, The risk or severity of adverse effects can be increased when Reteplase is combined with Collagenase clostridium histolyticum.]
[B01AD09, ancrod, The risk or severity of adverse effects can be increased when Ancrod is combined with Collagenase clostridium histolyticum.]
[S01AA04, oxytetracycline, The therapeutic efficacy of Collagenase clostridium histolyticum can be decreased when used in combination with Oxytetracycline.]
[B01AB09, danaparoid, The risk or severity of adverse effects can be increased when Danaparoid is combined with Collagenase clostridium histolyticum.]
[B01AA02, phenindione, The risk or severity of adverse effects can be increased when Phenindione is combined with Collagenase clostridium histolyticum.]
[B01AA04, phenprocoumon, The risk or severity of adverse effects can be increased when Phenprocoumon is combined with Collagenase clostridium histolyticum.]
[B01AC13, abciximab, The risk or severity of adverse effects can be increased when Abciximab is combined with Collagenase clostridium histolyticum.]
[S01XA13, alteplase, The risk or severity of adverse effects can be increased when Alteplase is combined with Collagenase clostridium histolyticum.]
[B01AC09, epoprostenol, The risk or severity of adverse effects can be increased when Epoprostenol is combined with Collagenase clostridium histolyticum.]
[J01AA09, rolitetracycline, The therapeutic efficacy of Collagenase clostridium histolyticum can be decreased when used in combination with Rolitetracycline.]
